(Total Views: 478)
Posted On: 01/04/2021 10:50:30 AM
Post# of 153940
Leronlimab's supply from Samsung is a huge advantage. The Merck/ OncoImmune "fusion protein" (now MK-7110) has great results, but, from SA:
"This deal includes ... the delivery of up to 100,000 doses of MK-7110 by June 30, 2021."
Not a lot.
"This deal includes ... the delivery of up to 100,000 doses of MK-7110 by June 30, 2021."
Not a lot.
(2)
(0)
